Advanced Search

Technical Analysis for ENTBF - Entheon Biomedical Corp

Grade Last Price % Change Price Change
F 0.51 -9.64% -0.0544
ENTBF closed down 9.64 percent on Friday, March 5, 2021, on 66 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical ENTBF trend table...
Date Alert Name Type % Chg
Reversal New Lows Setup Bearish Swing Setup 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Doji - Bullish? Reversal 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Older End-of-Day Signals for ENTBF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

_
Classification
Keywords:

Is ENTBF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Mar 3 Entheon Biomedical Announces Nancy Maher, Special Advisor of Data Science and Regulatory Affairs
Feb 24 Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences
Feb 22 Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study
Feb 16 Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian Jahns to Oversee Business Development
Feb 4 Entheon Biomedical Hires ClearTV Executive as VP of Digital Experience Entertainment Veteran Jonna Birgans to Oversee Digital and VR Content Development
Feb 2 Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments
Jan 22 Entheon Biomedical to be Included in First North American Psychedelic ETF
Jan 19 Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development
Jan 14 Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc.
Jan 12 Entheon Biomedical Engages Star Finance GmbH for Investor Relations
See more ENTBF news...

Indicators

Indicator Value
52 Week High 2.0
52 Week Low 0.3756
Average Volume 302,117
200-Day Moving Average 0.0000
50-Day Moving Average 0.7236
20-Day Moving Average 0.6891
10-Day Moving Average 0.6316
Average True Range 0.1203
ADX 35.01
+DI 21.3496
-DI 18.4805
Chandelier Exit (Long, 3 ATRs ) 0.4931
Chandelier Exit (Short, 3 ATRs ) 0.8609
Upper Bollinger Band 0.8455
Lower Bollinger Band 0.5327
Percent B (%b) -0.07
BandWidth 45.3925
MACD Line -0.0388
MACD Signal Line -0.0197
MACD Histogram -0.0191
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.7500
Resistance 3 (R3) 0.7733 0.7167 0.7100
Resistance 2 (R2) 0.7167 0.6555 0.7050 0.6967
Resistance 1 (R1) 0.6133 0.6178 0.6650 0.5900 0.6833
Pivot Point 0.5567 0.5567 0.5825 0.5450 0.5567
Support 1 (S1) 0.4533 0.4955 0.5050 0.4300 0.3367
Support 2 (S2) 0.3967 0.4578 0.3850 0.3233
Support 3 (S3) 0.2933 0.3967 0.3100
Support 4 (S4) 0.2700